price
KY
NASDAQ · KYTX
Kyverna Therapeutics, Inc.
Healthcare · Biotechnology
$7.35
Down-$0.29 (-3.80%)
Updated Sep 11, 2026, 3:05 AM
SID Score
3.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 364.57M
- P/E ratio
- -2.27
- Dividend yield
- 0.00%
- 52-week range
- $6.98 – $11.62
- Volume
- 854.46K
- Avg. volume
- 697.76K
Price performance
KYTX price history
1M range · 20 trading sessions · Daily adjusted prices
KYTX closed at $7.35 after 20 trading sessions, down 9.03% for the selected period.
- Last close
- $7.35
- Period change
- -9.03%
- Period low
- $7.35
- Period high
- $8.95
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $7.51 | $7.53 | $7.34 | $7.35 | 854.46K |
| Sep 9, 2026 | $8.00 | $8.165 | $7.595 | $7.64 | 918.29K |
| Sep 8, 2026 | $8.17 | $8.21 | $7.97 | $8.07 | 586.39K |
| Sep 4, 2026 | $8.26 | $8.38 | $8.20 | $8.25 | 500.82K |
| Sep 3, 2026 | $8.71 | $8.78 | $8.28 | $8.35 | 595.29K |
| Sep 2, 2026 | $8.37 | $8.72 | $8.24 | $8.615 | 599.97K |
| Sep 1, 2026 | $8.27 | $8.42 | $7.6001 | $8.35 | 1.78M |
| Aug 31, 2026 | $8.33 | $8.52 | $8.14 | $8.475 | 484.45K |
| Aug 28, 2026 | $8.52 | $8.55 | $8.31 | $8.37 | 524.93K |
| Aug 27, 2026 | $8.58 | $8.7867 | $8.45 | $8.64 | 432.43K |
| Aug 26, 2026 | $8.81 | $8.8388 | $8.5043 | $8.61 | 413.82K |
| Aug 25, 2026 | $8.36 | $8.885 | $8.265 | $8.84 | 778.21K |
| Aug 24, 2026 | $8.32 | $8.40 | $8.00 | $8.24 | 566.15K |
| Aug 21, 2026 | $8.24 | $8.58 | $8.19 | $8.42 | 663.61K |
| Aug 20, 2026 | $8.73 | $8.76 | $8.11 | $8.13 | 954.01K |
| Aug 19, 2026 | $8.81 | $9.14 | $8.64 | $8.87 | 796.72K |
| Aug 18, 2026 | $8.80 | $8.83 | $8.3612 | $8.50 | 851.46K |
| Aug 17, 2026 | $8.15 | $8.985 | $8.00 | $8.95 | 1.15M |
| Aug 14, 2026 | $8.10 | $8.29 | $7.80 | $8.17 | 580K |
| Aug 13, 2026 | $8.04 | $8.225 | $7.78 | $8.08 | 739.87K |
Latest KYTX news
The latest Smart Investors Daily articles mentioning KYTX.
Stock researchResearch & News · Analysis
Loading stock research…

